Artificial intelligence in musculoskeletal oncology imaging: A critical review of current applications - 04/01/23
Highlights |
• | Machine learning, deep learning and radiomic models can be applied to musculoskeletal oncology imaging. |
• | One limitation of radiomic studies is the lack of assessement of robustness of extracted features. |
• | Further efforts are needed for a routine use of artificial intelligence in musculoskeletal oncology imaging. |
Abstract |
Artificial intelligence (AI) is increasingly being studied in musculoskeletal oncology imaging. AI has been applied to both primary and secondary bone tumors and assessed for various predictive tasks that include detection, segmentation, classification, and prognosis. Still, in the field of clinical research, further efforts are needed to improve AI reproducibility and reach an acceptable level of evidence in musculoskeletal oncology. This review describes the basic principles of the most common AI techniques, including machine learning, deep learning and radiomics. Then, recent developments and current results of AI in the field of musculoskeletal oncology are presented. Finally, limitations and future perspectives of AI in this field are discussed.
Le texte complet de cet article est disponible en PDF.Keywords : Artificial intelligence, Bone tumor, Deep learning, Machine learning, Metastases
Abbreviations : ADC, AI, AUC, CNN, CT, DL, DSC, FDG, PET/CT, ML, MRI, PET-CT, RF, ROC, SPECT, SVM
Plan
Vol 104 - N° 1
P. 18-23 - janvier 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
